Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
2017 · New England Journal of Medicine · 8,809 citations
https://doi.org/10.1056/nejmoa1707914
R
Robert J. Glynn
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
26
Papers
16.6K
Citations
14
h-index
16
i10-index
Robert J. Glynn is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Lipoproteins and Cardiovascular Health & Inflammasome and immune disorders & Adipokines, Inflammation, and Metabolic Diseases. The author has an h-index of 14, co-authored 23 publications.
Papers by this author
worksLow-Dose Methotrexate for the Prevention of Atherosclerotic Events
2018 · New England Journal of Medicine · 1,264 citations
https://doi.org/10.1056/nejmoa1809798
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk
2022 · New England Journal of Medicine · 638 citations
https://doi.org/10.1056/nejmoa2210645
Inhibition of Interleukin-1β by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease
2018 · Journal of the American College of Cardiology · 273 citations
https://doi.org/10.1016/j.jacc.2018.03.490
Six-Year Effect of Depressive Symptoms on the Course of Physical Disability in Community-Living Older Adults
2000 · Archives of Internal Medicine · 174 citations
https://doi.org/10.1001/archinte.160.20.3074
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat